These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28805528)

  • 1. PACE investigators' response is misleading regarding patient survey results.
    Kirke KD
    J Health Psychol; 2017 Aug; 22(9):1168-1176. PubMed ID: 28805528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do graded activity therapies cause harm in chronic fatigue syndrome?
    Kindlon T
    J Health Psychol; 2017 Aug; 22(9):1146-1154. PubMed ID: 28805516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACE trial claims for recovery in myalgic encephalomyelitis/chronic fatigue syndrome - true or false? It's time for an independent review of the methodology and results.
    Shepherd CB
    J Health Psychol; 2017 Aug; 22(9):1187-1191. PubMed ID: 28805522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACE trial authors continue to ignore their own null effect.
    Vink M
    J Health Psychol; 2017 Aug; 22(9):1134-1140. PubMed ID: 28805519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias, misleading information and lack of respect for alternative views have distorted perceptions of myalgic encephalomyelitis/chronic fatigue syndrome and its treatment.
    Goudsmit E; Howes S
    J Health Psychol; 2017 Aug; 22(9):1159-1167. PubMed ID: 28805527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic fatigue syndrome patients have no reason to accept the PACE trial results: Response to Keith J Petrie and John Weinman.
    Agardy S
    J Health Psychol; 2017 Aug; 22(9):1206-1208. PubMed ID: 28805512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACE team response shows a disregard for the principles of science.
    Edwards J
    J Health Psychol; 2017 Aug; 22(9):1155-1158. PubMed ID: 28805520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to the editorial by Dr Geraghty.
    White PD; Chalder T; Sharpe M; Angus BJ; Baber HL; Bavinton J; Burgess M; Clark LV; Cox DL; DeCesare JC; Goldsmith KA; Johnson AL; McCrone P; Murphy G; Murphy M; O'Dowd H; Potts L; Walwyn R; Wilks D
    J Health Psychol; 2017 Aug; 22(9):1113-1117. PubMed ID: 28805524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PACE trial missteps on pacing and patient selection.
    Jason LA
    J Health Psychol; 2017 Aug; 22(9):1141-1145. PubMed ID: 28805518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy.
    White PD; Sharpe MC; Chalder T; DeCesare JC; Walwyn R;
    BMC Neurol; 2007 Mar; 7():6. PubMed ID: 17397525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al.
    Sharpe M; Goldsmith K; Chalder T
    BMC Psychol; 2019 Mar; 7(1):15. PubMed ID: 30871632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACE-GATE: An alternative view on a study with a poor trial protocol.
    Stouten B
    J Health Psychol; 2017 Aug; 22(9):1192-1197. PubMed ID: 28805525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The problem of bias in behavioural intervention studies: Lessons from the PACE trial.
    Wilshire C
    J Health Psychol; 2017 Aug; 22(9):1128-1133. PubMed ID: 28805526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an online survey to explore positive and negative outcomes of rehabilitation for people with CFS/ME.
    Gladwell PW; Pheby D; Rodriguez T; Poland F
    Disabil Rehabil; 2014; 36(5):387-94. PubMed ID: 23735013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys.
    Geraghty K; Hann M; Kurtev S
    J Health Psychol; 2019 Sep; 24(10):1318-1333. PubMed ID: 28847166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigator bias and the PACE trial.
    Lubet S
    J Health Psychol; 2017 Aug; 22(9):1123-1127. PubMed ID: 28805514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further commentary on the PACE trial: Biased methods and unreliable outcomes.
    Geraghty KJ
    J Health Psychol; 2017 Aug; 22(9):1209-1216. PubMed ID: 28805517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
    Twisk FN; Maes M
    Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once again, the PACE authors respond to concerns with empty answers.
    Tuller D
    J Health Psychol; 2017 Aug; 22(9):1118-1122. PubMed ID: 28805521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter.
    Geraghty KJ; Blease C
    Disabil Rehabil; 2019 Dec; 41(25):3092-3102. PubMed ID: 29929450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.